Accuracy of budget impact estimations and impact on patient access : a hepatitis C case study
Year of publication: |
2019
|
---|---|
Authors: | Geenen, Joost W. ; Boersma, Cornelis ; Klungel, Olaf H. ; Hövels, Anke M. |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 20.2019, 6, p. 857-867
|
Subject: | Affordability | Budget impact | Budget impact accuracy | Direct-acting antivirals | Hepatitis C | Pharmaceuticals | Gesundheitskosten | Health care costs | Öffentlicher Haushalt | Public budget | Arzneimittel | USA | United States | Gesundheitsversorgung | Health care | Infektionskrankheit | Infectious disease |
-
Value appropriation in hepatitis C
Lindgren, Peter, (2022)
-
Policy response to pandemic influenza : the value of collective action
Bobashev, Georgiy, (2011)
-
Country versus pharmaceutical company interests for hepatitis C treatment
Lothan, Roy, (2022)
- More ...
-
Geenen, Joost W., (2020)
-
Herings, Ronald M.C., (2001)
-
Economic Evaluations of Cholesterol-Lowering Drugs: A Critical and Systematic Review
Gumbs, Pearl D., (2007)
- More ...